Title Pocket Guide to Radiation Oncology, 2/e
Subtitle
Author Daniel D. Chamberlain, James B. Yu, Roy H. Decker
ISBN 9780826155139
List price USD 60.00
Price outside India Available on Request
Original price
Binding Paperback
No of pages 366
Book size 114 x 178 mm
Publishing year 2021
Original publisher Demos Medical Publishing
Published in India by .
Exclusive distributors Viva Books Private Limited
Sales territory Bangladesh, India, Pakistan, Sri Lanka
Status New Arrival
About the book Send Enquiry
  
 

Description:

Now in its second edition, this practical guide to clinical radiation oncology is the ideal pocket companion for the practicing physician during rounds and other clinical settings. Organized by site-specific diseases, chapters present the must-know key points, including treatment options by stage, technical considerations, and important items for follow-up. Clinical pearls and tables covering treatment options, dose constraints, side effects, target delineations, and treatment planning complete each chapter.

The pocket guide includes updates to all chapters and covers topics new to this edition, such as oligometastatic disease, benign indications, and a chapter dedicated to proton therapy considerations. Written in outline format, Pocket Guide to Radiation Oncology takes an efficient and no-frills approach to fundamental topics in the field, making it the perfect reference for a quick review for the board exam or MOC and even serving as a handy reference during a case review at a tumor board.

 

Key Features:

  • Chapters conclude with a list of selected, summarized studies relevant to the disease
  • Provides essential, quick reference appendices on radiation therapy symptom management, normal tissue tolerance constraints, and radiation therapy and new systemic agents
  • 54 disease-based chapters make it easy to find sites without having to sift through dense, broad text


Contents:

Contributors
Preface

PART I: CENTRAL NERVOUS SYSTEM NEOPLASMS
Chapter 1: Brain Metastasis (Yi An)
Chapter 2: Glioblastoma Multiforme and High-Grade Glioma (Yi An)
Chapter 3: Low Grade Glioma (Wesley Talcott and Joseph N. Contessa)
Chapter 4: Meningioma (Gabrielle W Peters and Joseph N. Contessa)
Chapter 5: Vestibular Schwannoma (Daniel D. Chamberlain)
Chapter 6: Pituitary Tumors (Yi An)

Central Nervous System Treatment Planning Dose Constraints

PART II: HEAD AND NECK CANCERS
Chapter 7: Nasopharynx Cancer (Henry S. Park and Melissa R. Young)
Chapter 8: Nasal Cavity and Paranasal Sinus (Henry S. Park and Melissa R. Young)
Chapter 9: Oropharynx Cancer (Henry S. Park and Melissa R. Young)
Chapter 10: Oral Cavity and Lip Cancers (Melissa R. Young and Henry S. Park)
Chapter 11: Major Salivary Gland Tumors (Melissa R. Young and Henry S. Park)
Chapter 12: Larynx and Hypopharynx Cancers (Henry S. Park and Melissa R. Young)
Chapter 13: Thyroid Cancer (Henry S. Park, Patricia R. Peter, and Melissa R. Young)
Chapter 14: Occult Primary Cancer of the Head and Neck (Melissa R. Young and Henry S. Park)

Head and Neck Treatment Planning Dose Constraints

PART III: THORACIC CANCERS
Chapter 15: Non-Small Cell Lung Cancer (Daniel D. Chamberlain)
Chapter 16: Small Cell Lung Cancer (Brandon R. Mancini and Roy H. Decker)
Chapter 17: Mesothelioma (Brandon R. Mancini and Roy H. Decker)
Chapter 18: Thymoma and Thymic Carcinoma (Brandon R. Mancini and Roy H. Decker)

Thoracic Treatment Planning Dose Constraints

PART IV: BREAST CANCER
Chapter 19: Breast Cancer (Christin A. Knowlton and Meena S. Moran)

Breast Treatment Planning Dose Constraints

PART V: GASTROINTESTINAL CANCERS
Chapter 20: Esophageal Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)
Chapter 21: Gastric Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)
Chapter 22: Hepatobiliary Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)
Chapter 23: Pancreatic Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)
Chapter 24: Rectal Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)
Chapter 25: Anal Cancer (Gabrielle W. Peters, Charles E. Rutter, and Kimberly L. Johung)

Gastrointestinal Treatment Planning Dose Constraints

PART VI: GYNECOLOGIC CANCERS
Chapter 26: Ovarian Cancer (James Laird, Joan R. Tymon-Rosario, and Shari Damast)
Chapter 27: Endometrial Cancer (James Laird, Yi An, and Shari Damast)
Chapter 28: Cervical Cancer (James Laird, Melissa R. Young, and Shari Damast)
Chapter 29: Vaginal Cancer (James Laird and Shari Damast)
Chapter 30: Vulvar Cancer (James Laird, Melissa R. Young, and Shari Damast)

Gynecologic Treatment Planning Dose Constraints

PART VII: GENITOURINARY CANCERS
Chapter 31: Prostate Intact (David G. Wallington and Brandon R. Mancini)
Chapter 32: Adjuvant/Salvage Prostate Cancer Treatment (David G. Wallington and Brandon R. Mancini)
Chapter 33: Bladder Cancer (David G. Wallington and Brandon R. Mancini)
Chapter 34: Seminoma (David G. Wallington and Brandon R. Mancini)

Genitourinary Treatment Planning Dose Constraints

PART VIII: LYMPHOMA
Chapter 35: Hodgkin Lymphoma (Shang-Jui Wang and Rahul R. Parikh)
Chapter 36: Non-Hodgkin Lymphoma (Shang-Jui Wang and Rahul R. Parikh)
Chapter 37: Multiple Myeloma and Plasmacytoma (Shang-Jui Wang and Rahul R. Parikh)
Chapter 38: Cutaneous Lymphoma (Shang-Jui Wang and Rahul R. Parikh)

Lymphoma Treatment Planning Dose Constraints

PART IX: SARCOMA
Chapter 39: Soft Tissue Sarcoma (Andrew J. Bishop and B. Ashleigh Guadagnolo)

Sarcoma Treatment Planning Dose Constraints

PART X: SKIN CANCERS
Chapter 40: Cutaneous Squamous Cell and Basal Cell Carcinomas (Anna Likhacheva)
Chapter 41: Malignant Melanoma (Anna Likhacheva)
Chapter 42: Merkel Cell Carcinoma (Anna Likhacheva)

PART XI: PEDIATRIC MALIGNANCIES
Chapter 43: Ependymoma (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 44: Medulloblastoma (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 45: Neuroblastoma (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 46: Wilms’ Tumor (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 47: Rhabdomyosarcoma (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 48: Ewing’s Sarcoma (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)
Chapter 49: Pediatric Leukemia (Amit Roy, Sahaja Acharya, and Stephanie M. Perkins)

PART XII: METASTATIC DISEASE
Chapter 50: Oligometastatic Disease (Daniel D. Chamberlain)
Chapter 51: Palliative Radiation (Yi An)

PART XIII: BENIGN INDICATIONS
Chapter 52: Benign Fibromatoses (Wesley Talcott and James Yu)
Chapter 53: Keloids (Wesley Talcott and James Yu)
Chapter 54: Heterotopic Ossification (Wesley Talcott and James Yu)

PART XIV: TECHNIQUES
Chapter 55: Proton Radiation Therapy (Cristina M. DeCesaris, Jenna Jatczak, Sina Mossahebi, and Mark V Mishra)

Appendix 1: Common Medications in Radiation Oncology
Appendix 2: Normal Tissue Tolerances
Appendix 3: Radiation and Targeted or Immunotherapeutic Agents
Index


About the Editors:

Daniel D. Chamberlain, MD, Division Chief, Radiation Oncology, West Michigan Cancer Center, Kalamazoo, Michigan.

James B. Yu, MD, MHS, Professor of Therapeutic Radiology; Medical Director, Smilow Radiation Oncology; Director, Prostate and Genitourinary Cancer Radiotherapy Program, Yale University School of Medicine, New Haven, Connecticut.

Roy H. Decker, MD, PhD, Professor, Residency Training Program Director, Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.


Target Audience:

This book is useful for practicing physicians and clinical radiation oncologists.

 

 
Special prices are applicable to the authorised sales territory only.
Prices are subject to change without prior notice.